IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers
Status:
Completed
Trial end date:
2021-05-27
Target enrollment:
Participant gender:
Summary
A Phase I, Open-label, Fixed-Sequence Study to Evaluate the Effect of Multiple-dose
Itraconazole or Rifampicin Capsules on the Single-dose PK Profiles of IMP4297 Capsules in
Healthy Subjects